DELIVERY ORDER
Active75F40126F19001
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$1.2M
obligated · signed 7 days ago
FFP TASK ORDER FOR PROTON PUMP INHIBITOR PK STUDY FOR THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF GENERIC DRUGS (OGD).
Performance timeline
Start
Sep 30, 2026
Current end
Mar 29, 2028
Potential end
Sep 29, 2029
with all options
Loading status
Estimated start: Sep 29, 2028
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC
Contract 75F40126F19001
UEI
FWWJT8QCEDY4
Parent Company
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC
Capabilities & Certifications
Headquarters Location
Congressional District: 36
Current Obligation
$1,227,674
Base + Exercised Options
$1,227,674
Total Ceiling Value
$2,103,785
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Contract Vehicle
75F40125D00003
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.